Timolol maleate
APPLICABILITY OF BIVARIATE CALIBRATION ALGORITHM AND VIERORDT METHOD FOR SIMULTANEOUS DETERMINATION OF TIMOLOL MALEATE AND BRIMONIDINE TARTRATE IN THEIR BINARY MIXTURE AND PHARMACEUTICAL DOSAGE FORM
11
DEVELOPMENT AND INVESTIGATION OF TIMOLOL MALEATE AND LATANOPROST COMBINATION LIPOSOMES FOR THE TREATMENT OF GLAUCOMA
9
Efficacy and safety of a switch to latanoprost 0.005% + timolol maleate 0.5% fixed combination eyedrops from latanoprost 0.005% monotherapy
5
Efficacy and safety of switching to latanoprost 0.005%–timolol maleate 0.5% fixed-combination eyedrops from an unfixed combination for 36 months
5
SIMULTANEOUS QUANTIFICATION OF TRAVOPROST AND TIMOLOL MALEATE IN PHARMACEUTICAL FORMULATION BY RP HPLC
5
DERIVATIVE SPECTROPHOTOMETRIC METHOD FOR ESTIMATION OF BRIMONIDINE TARTRATE & TIMOLOL MALEATE IN COMBINATION
7
The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies
9
Formulation, Development and Evaluation of Timolol Maleate Sustained Release Matrix Tablets
78
Ocular insert of Timolol Maleate using naturally occurring biodegradable polymer
10
Simultaneous RP HPLC determination of Latanoprost and Timolol Maleate in combined pharmaceutical dosage form
7
DESIGN AND OPTIMIZATION OF CONTROLLED RELEASE OCULAR INSERTS OF DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE FOR TREATMENT OF GLAUCOMA
8
Ocular hypotensive effect and safety of travoprost 0.004%/timolol maleate 0.5% fixed combination after change of treatment regimen from ß-blockers and prostaglandin analogs
5
DEVELOPMENT, OPTIMIZATION AND ENHANCEMENT OF TRANSCORNEAL PERMEATION OF TIMOLOL MALEATE FROM A NOVEL IN SITU GEL
21
RCT of Timolol Maleate Gel for Superficial Infantile Hemangiomas in 5- to 24-Week-Olds
11
PREPARATION AND EVALUATION OF TIMOLOL MALEATE MATRIX TABLET USING HYDROGEL FORMING POLYSACCHARIDES
9
Topical Timolol Maleate Treatment of Infantile Hemangiomas
11
Design & characterization of timolol maleate Osmotic drug delivery system
14
Formulation and Evaluation of Sustained-Release Matrix Tablets of Timolol Maleate.
141
Formulation Development and Evaluation of Ophthalmic Solution of Timolol Maleate 0.5%
129
Conjunctival changes and inflammatory aspects in rabbits' conjunctivas induced by fixed combinations of prostaglandin analogues and timolol maleate
7